VISTAGEN THERAPEUTICS, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-12-31 was $7.00K.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2022-09-30 was $4.40K, a 90.24% decline year-over-year.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2022-06-30 was $100.00K, a 675.19% increase year-over-year.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2021-12-31 was $58.00K.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2026 was $8.00K.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $104.00K.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $0.00.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2021 was $0.00.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-03-31 | $8.00K 10-K · filed 2026-06-15 | |
| 2025-12-31 | $7.00K 10-Q · filed 2026-02-12 | |
| 2023-03-31 | $104.00K 10-K · filed 2024-06-11 | |
| 2022-09-30 | $4.40K 10-Q · filed 2024-02-13 | |
| 2022-06-30 | $100.00K 10-Q · filed 2024-02-13 | |
| 2022-03-31 | $0.00 10-K · filed 2023-06-28 | |
| 2021-12-31 | $58.00K 10-Q · filed 2023-02-07 | |
| 2021-09-30 | $45.10K 10-Q · filed 2023-02-07 | |
| 2021-06-30 | $12.90K 10-Q · filed 2023-02-07 | |
| 2021-03-31 | $0.00 10-K · filed 2022-06-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |